Appointment of Independent Director in the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare's board, at its May 30, 2025 meeting, approved the audited standalone and consolidated financial results for Q4 and the full financial year ended March 31, 2025. The board also appointed Ms. Krupalibahen Rajeshbhai Mehta (DIN: 11109785) as an Additional Non-Executive Independent Director for a 5-year term starting May 30, 2025, subject to shareholder approval. The new director holds no shares in the company and is not related to any existing director, KMP, or promoter. Notably, the auditor's report on the financial results is a qualified report, meaning the auditor flagged certain matters in their opinion. The appointee's background is in Sanskrit studies, and the company states she brings ethical and cultural perspective to governance.
The independent director appointment strengthens board composition and is a routine governance action, but shareholders should note the qualified audit report which warrants review of the full results for any underlying concerns. No material disruption to operations or leadership is implied.